tranexamic acid has been researched along with Carcinoma, Anaplastic in 4 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The primary study objective is to determine the effect of perioperative treatment with either intravenous iron, tranexamic acid or with a combination of both medicines on the reduction of intraoperative and postoperative red blood cell transfusions in gynaecological carcinoma patients." | 9.51 | Perioperative management with ferric carboxymaltose and tranexamic acid to reduce transfusion rate in gynaecological carcinoma surgery (TRANAFER-Study): study protocol for a single-blind, monocentre, randomised trial. ( Amstad, G; Geiger, J; Heinzelmann, V; Montavon, C; Werlen, L, 2022) |
| "In the present phase II trial, 26 heavily pretreated patients with advanced recurrent ovarian carcinoma were treated with tranexamic acid, 4-6 g per os daily for at least 3 months." | 7.66 | Tranexamic acid for the treatment of advanced ovarian carcinoma. ( Johnsson, JE; Sigurdsson, K; Tropé, C, 1983) |
| "The antifibrinolytic action of tranexamic acid (AMCHA) on the growth and metastasis of rabbit V2 carcinoma having high fibrinolytic activity was studied." | 7.66 | Effect of tranexamic acid on the growth and metastasis of V2 carcinoma in rabbits. ( Kodama, Y; Tanaka, K, 1981) |
| " The primary study objective is to determine the effect of perioperative treatment with either intravenous iron, tranexamic acid or with a combination of both medicines on the reduction of intraoperative and postoperative red blood cell transfusions in gynaecological carcinoma patients." | 5.51 | Perioperative management with ferric carboxymaltose and tranexamic acid to reduce transfusion rate in gynaecological carcinoma surgery (TRANAFER-Study): study protocol for a single-blind, monocentre, randomised trial. ( Amstad, G; Geiger, J; Heinzelmann, V; Montavon, C; Werlen, L, 2022) |
| "Eleven patients with advanced ovarian carcinoma who had large quantities of ascites during the course of previous chemotherapy were tested with intraperitoneal injections of tranexamic acid, followed by combination chemotherapy." | 3.67 | Adjuvant effects of tranexamic acid to chemotherapy in ovarian cancer patients with large amount of ascites. ( Kato, K; Kikuchi, Y; Kizawa, I; Matsuda, M; Oomori, K, 1986) |
| "In the present phase II trial, 26 heavily pretreated patients with advanced recurrent ovarian carcinoma were treated with tranexamic acid, 4-6 g per os daily for at least 3 months." | 3.66 | Tranexamic acid for the treatment of advanced ovarian carcinoma. ( Johnsson, JE; Sigurdsson, K; Tropé, C, 1983) |
| "The antifibrinolytic action of tranexamic acid (AMCHA) on the growth and metastasis of rabbit V2 carcinoma having high fibrinolytic activity was studied." | 3.66 | Effect of tranexamic acid on the growth and metastasis of V2 carcinoma in rabbits. ( Kodama, Y; Tanaka, K, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amstad, G | 1 |
| Geiger, J | 1 |
| Werlen, L | 1 |
| Montavon, C | 1 |
| Heinzelmann, V | 1 |
| Sigurdsson, K | 1 |
| Johnsson, JE | 1 |
| Tropé, C | 1 |
| Kodama, Y | 1 |
| Tanaka, K | 1 |
| Kikuchi, Y | 1 |
| Kizawa, I | 1 |
| Oomori, K | 1 |
| Matsuda, M | 1 |
| Kato, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Serum Hepcidin and Iron Status Parameters in Pregnant Women and the Association With Adverse Maternal and Fetal Outcome[NCT03792464] | 188 participants (Actual) | Observational | 2019-04-30 | Completed | |||
| Iron Prehabilitation and Perioperative Infectious Diseases of Endometrial Cancer Patients[NCT06049693] | Phase 4 | 100 participants (Anticipated) | Interventional | 2023-01-01 | Enrolling by invitation | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for tranexamic acid and Carcinoma, Anaplastic
3 other studies available for tranexamic acid and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Tranexamic acid for the treatment of advanced ovarian carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Carcinoma; Cyclohexanecarboxylic Acids; Drug | 1983 |
Effect of tranexamic acid on the growth and metastasis of V2 carcinoma in rabbits.
Topics: Animals; Carcinoma; Cyclohexanecarboxylic Acids; Fibrin; Fibrinolysis; Lung Neoplasms; Lymphatic Met | 1981 |
Adjuvant effects of tranexamic acid to chemotherapy in ovarian cancer patients with large amount of ascites.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Carcinoma; Cyclohexanecarboxyl | 1986 |